Archive 081120 MEDIA MOMENTS | Quest Clinical

top of page

Clinical Research Studies

Quest carries out Phase I, II, and III studies for pharmaceutical and research companies operating in the following therapeutic areas:

HIV (cure, research, & treatment)
Hepatitis B (cure & research)
NASH/Fatty Liver

Learn More Or Enroll

Triple Negative Breast Cancer
Solid Tumor Cancers

Media Moments

Click Play for 'Call Dr. Jay' Song

Click Play for 'I feel terrible' flu ad

08/05/20: Cytodyn's Leromlimab receives positive DSMC recommendation in ongoing

Phase 3 study

Screen Shot 2020-05-18 at 8.01.51 PM.png

05/18/20: CytoDyn to submit trial designs of remdesivir vs leronlimab and in combination to battle coronavirus

04/21/20: Growing evidence that HIV drug could be game-changer in COVID-19 fight

04/01/20: SF doc sees promise in HIV drug as treatment for COVID19

Screen Shot 2020-04-08 at 4.28.53 PM.png

Dr Jay Speaks at EASL 2019: On the road to a cure for Hep B

Screen Shot 2020-05-03 at 7.31.07 AM.png

Dr Jay presents BMS oral attachment inhibitor at CROI 2014

2Screen Shot 2020-05-02 at 9.49.58 PM co

Ibalizumab reduces viral load in patients with MDR HIV

ICAAC 2007: Oral CCR5 inhibitor drug revolutionary for the treatment of some HIV infections

download (1).jpeg

1996 AIDS Conference: COMBINATION THERAPY CAN TREAT AIDS

Screen Shot 2020-04-24 at 1.51.04 PM.png

Flu Treatment

CBS NEWS

Rukobia+Product+Shot.jpg

07/02/20: ViiV Healthcare receives FDA approval for Rukobia, a treatment for drug-resistant HIV

3Screen Shot 2020-04-24 at 2.22.53 PM.jp

04/23/20: San Francisco researchers weigh in on coronavirus drugs being studied Kron 4 News

04/21/20: Developing Leronlimab as COVID-19 treatment

listen now >

Positive Clinical Responses for Two Breast Cancer Patients

3Screen Shot 2020-05-02 at 9.10.30 AM.jp

Your Money or Your Life

Dr. Jay & Bernie Sanders speak on the high cost of Hepitis C treatment

Altered Immune Cells Block HIV

Discover Magazine's #2 story of 2012

Dr Jay’s research coordinator, Derek, proposes marriage at Burning Man

2006: Antibody to CCR5 receptor safe, effective, suitable for weekly dosing, preliminary study shows | aidsmap

Screen Shot 2020-04-24 at 1.16.31 PM.png

Herpevac (Herpes vaccine)

ABC NEWS

Screen Shot 2020-04-24 at 1.47.44 PM.png

CMV Retinitis

TV NEWS

Anchor 1

bottom of page